These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3943989)

  • 1. Twice-a-day radiation therapy for supraglottic carcinoma.
    Wang CC; Suit HD; Blitzer PH
    Int J Radiat Oncol Biol Phys; 1986 Jan; 12(1):3-7. PubMed ID: 3943989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperfractionated radiation in the treatment of squamous cell carcinomas of the head and neck: a comparison of two fractionation schedules.
    Garden AS; Morrison WH; Ang KK; Peters LJ
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):493-502. PubMed ID: 7852111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of accelerated fractionated irradiation for supraglottic carcinoma: assessment of results.
    Wang CC; Nakfoor BM; Spiro IJ; Martins P
    Cancer J Sci Am; 1997; 3(2):88-91. PubMed ID: 9099458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Twice-a-day radiation therapy for cancer of the head and neck.
    Wang CC; Blitzer PH; Suit HD
    Cancer; 1985 May; 55(9 Suppl):2100-4. PubMed ID: 3919925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma.
    Le QT; Fu KK; Kroll S; Ryu JK; Quivey JM; Meyler TS; Krieg RM; Phillips TL
    Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):115-26. PubMed ID: 9300746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose, time, and fraction size issues for late effects in head and neck cancers.
    Taylor JM; Mendenhall WM; Lavey RS
    Int J Radiat Oncol Biol Phys; 1992; 22(1):3-11. PubMed ID: 1727126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved local control for advanced oropharyngeal carcinoma following twice daily radiation therapy.
    Wang CC
    Am J Clin Oncol; 1985 Dec; 8(6):512-6. PubMed ID: 4083268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperfractionated radiotherapy in the treatment of squamous cell carcinomas of the supraglottic larynx.
    Wendt CD; Peters LJ; Ang KK; Morrison WH; Maor MH; Goepfert H; Oswald MJ
    Int J Radiat Oncol Biol Phys; 1989 Nov; 17(5):1057-62. PubMed ID: 2808039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of early glottic and supraglottic carcinoma treated with conventional fractionation of radiotherapy.
    Inoue T; Inoue T; Ikeda H; Teshima T; Yamazaki H; Murayama S; Othani M; Ozeki S
    Strahlenther Onkol; 1993 Oct; 169(10):584-9. PubMed ID: 8235982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local control of oropharyngeal carcinoma after two accelerated hyperfractionation radiation therapy schemes.
    Wang CC
    Int J Radiat Oncol Biol Phys; 1988 Jun; 14(6):1143-6. PubMed ID: 3384716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of postradiotherapy neck dissection in supraglottic carcinoma.
    Chan AW; Ancukiewicz M; Carballo N; Montgomery W; Wang CC
    Int J Radiat Oncol Biol Phys; 2001 Jun; 50(2):367-75. PubMed ID: 11380223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local control of T3 carcinomas after accelerated fractionation: a look at the "gap".
    Wang CC; Efird J; Nakfoor B; Martins P
    Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):439-41. PubMed ID: 8655365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of radiotherapy for T2N0 glottic carcinoma: does the "2" stand for twice-daily treatment?
    Garden AS; Forster K; Wong PF; Morrison WH; Schechter NR; Ang KK
    Int J Radiat Oncol Biol Phys; 2003 Feb; 55(2):322-8. PubMed ID: 12527044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Definitive radiation therapy for moderately advanced laryngeal cancer: effects of accelerated hyperfractionation.
    Okubo M; Nishimura Y; Shibata T; Nakamatsu K; Kanamori S; Tachibana I; Koike R; Nishikawa T; Mori K
    Jpn J Clin Oncol; 2010 Oct; 40(10):944-8. PubMed ID: 20534687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation therapy in early glottic carcinoma: uni- and multivariate analysis of prognostic factors affecting local control.
    Sakata K; Aoki Y; Karasawa K; Hasezawa K; Muta N; Nakagawa K; Terahara A; Onogi Y; Sasaki Y; Akanuma A
    Int J Radiat Oncol Biol Phys; 1994 Dec; 30(5):1059-64. PubMed ID: 7961012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Radiotherapy of carcinoma of the larynx--dose and function preservation].
    Nakano M; Iida K; Sato S; Sakata S; Sueyama H
    Gan No Rinsho; 1985 Sep; 31(12):1602-4. PubMed ID: 4079049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deciding on optimal management of supraglottic carcinoma.
    Wang CC; Montgomery WW
    Oncology (Williston Park); 1991 Apr; 5(4):41-6; discussion 46, 49, 53. PubMed ID: 1831039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regression after 50 Gy as a selection for therapy in advanced laryngeal cancer.
    Terhaard CH; Wiggenraad RG; Hordijk GJ; Ravasz LA
    Int J Radiat Oncol Biol Phys; 1988 Sep; 15(3):591-7. PubMed ID: 3138211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical results of conventional fractionation radiotherapy for glottic and supraglottic laryngeal cancers--the usefulness of hyperfractionation for these cancers].
    Masunaga S; Ono K; Tsutsui K; Abe M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Feb; 50(2):139-45. PubMed ID: 2362794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why to start the concomitant boost in accelerated radiotherapy for advanced laryngeal cancer in week 3.
    Terhaard CH; Kal HB; Hordijk GJ
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):62-9. PubMed ID: 15850903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.